Compare Amphastar Pharmaceuticals Inc (AMPH) vs Innovative Industrial Properties Inc (IIPR) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

IIPR trades at $64.44, up 2.16% with a bullish technical signal from moving averages. The REIT shows strong profitability with 45.58% net margins and stable quarterly earnings beats. Recent developments include successful debt refinancing and a $1.90 quarterly dividend declaration. Valuation appears reasonable with P/E of 16.44 and P/B of 1.05, though revenue declined to $266M in 2025.

Outlook remains positive with cannabis rescheduling progress and improved capital structure, but risks include tenant credit quality and sector volatility. The 13.32% dividend yield offers income appeal, though coverage requires monitoring. Analyst consensus leans cautious with 36% buy ratings amid revenue pressure.